![Anti-CD147 Antibody [MEM-M6/1] (FITC) (A85527) | Antibodies.com](https://cdn.antibodies.com/image/catalog/85/A85527_41.jpg?profile=product_top "Anti-CD147 Antibody [MEM-M6/1] (FITC) (A85527) | Antibodies.com")
Anti-CD147 Antibody [MEM-M6/1] (FITC) (A85527) | Antibodies.com
Cancers | Free Full-Text | CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells | Signal Transduction and Targeted Therapy
EMMPRIN/CD147 plays a detrimental role in clinical and experimental ischemic stroke - Figure f7 | Aging
Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation | Stroke
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells | Signal Transduction and Targeted Therapy
A novel mouse model to test SARS-CoV-2 viral infection
CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target - ScienceDirect
Cancers | Free Full-Text | CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
CD147 deficiency in T cells prevents thymic involution by inhibiting the EMT process in TECs in the presence of TGFβ | Cellular & Molecular Immunology
Links between CD147 Function, Glycosylation, and Caveolin-1 | Molecular Biology of the Cell
IJMS | Free Full-Text | CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma
Cancer-related Issues of CD147 | Cancer Genomics & Proteomics
Cells | Free Full-Text | SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
CD147, a New Target of SARS-CoV-2 Invasion-CUSABIO
CD147 Polyclonal Antibody (34-5600)
CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review)
CD147, a New Target of SARS-CoV-2 Invasion-CUSABIO
Frontiers | Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin
CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis | Scientific Reports
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement | SpringerLink
CD147 Monoclonal Antibody (RL73), Functional Grade (16-1471-82)
CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review)
